Moreover, LTS showed an increased expression of antitumor immune markers such as CD8+, CD3+ and Granzyme B+ cells within the tumor, suggesting the intratumor microbiome may promote immune activation within the tumor microenvironment, promoting a more robust antitumor immune response. This evidence concerns the gene CD8A and neoplasm.